Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor
Primary Purpose
Coronary Artery Disease, Coronary Stenosis, Coronary Microvascular Disease
Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Intra coronary rapid-exchange iKOs microcatheter intervention
Sponsored by
About this trial
This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring Heart, Microcatheter, Fibreoptic
Eligibility Criteria
Inclusion Criteria:
- Able and willing to give informed consent
- >18 years old
- Have a clinical diagnosis of coronary artery disease
- Undergoing further assessment of a coronary artery with a pressure wire study
Exclusion Criteria:
General
- Previous coronary artery bypass grafting.
- Non/ST-elevation myocardial infarction as indication for angiography.
- Ongoing evidence of ischaemia at rest.
- Severe renal impairment (GFR <25).
- Severe anaemia (Hb <10).
- Heparin allergy.
- Atrial fibrillation.
- Contraindication to adenosine.
- Pregnant or lactating; or female of childbearing potential.
- Participation in other interventional studies.
Additional exclusion criteria at Angiogram:
- Critical coronary artery stenosis in the vessel which is to be studied (>90%).
- Left main stem coronary disease causing a >50% stenosis.
- Triple vessel coronary disease.
Sites / Locations
- St Bartholomew's HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intra coronary rapid-exchange iKOs microcatheter intervention
Arm Description
Patients with coronary heart disease and undergoing coronary physiology investigations (pressure wire measurements) will have additional coronary pressure and flow measurements using the iKOs rapid-exchange microcatheter and iKOr console.
Outcomes
Primary Outcome Measures
To assess the effectiveness of the iKOr system in measuring temperature change (flow) in patients with coronary artery disease undergoing physiology investigations
A change in thermal transit time measured by the iKOr system
Secondary Outcome Measures
To assess the safety of the iKOs microcatheter in patients undergoing angiography and pressure wire assessment
The number of major adverse cardiac events or patient deaths
To assess the safety of the iKOs microcatheter procedure
The number of procedural complications related to the device (operator observed vessel spasm, vascular complications, bleeding)
To assess the effect of the iKOs microcatheter on cardiac injury
The change in Troponin levels
To assess the effect of the iKOs microcatheter on TIMI (Thrombolysis In Myocardial Infarction) flow
The change in TIMI (Thrombolysis In Myocardial Infarction) flow
Full Information
NCT ID
NCT05346458
First Posted
March 9, 2022
Last Updated
May 30, 2023
Sponsor
Queen Mary University of London
Collaborators
Echopoint Medical Ltd
1. Study Identification
Unique Protocol Identification Number
NCT05346458
Brief Title
Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor
Official Title
A Single Centre, Prospective, Feasibility Study of the iKOs™ Coronary Pressure and Flow Rapid-exchange Microcatheter and iKOr™ Console in Patients With Coronary Heart Disease Undergoing Coronary Physiology Investigations
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 14, 2022 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
November 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Queen Mary University of London
Collaborators
Echopoint Medical Ltd
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this investigation is to see if the newly developed "iKOs™ microcatheter" can safely and accurately measure flow and pressure within the heart arteries of 10 patients undergoing angiogram and pressure wire tests.
Detailed Description
After being informed about the study and the potential risks and benefits, participants who provide written consent will be screened to make sure they fulfil the study entry requirements. Those who are assessed as eligible will undergo baseline assessments and preparation for their angiogram.
Once enrolled they will undergo coronary angiography at the start of their clinical procedure. The angiogram will be examined by the Investigator and a decision made if the target vessel is suitable for a pressure wire study and insertion of the investigational device. If the investigator confirms that the participant remains eligible and the study part can go ahead, the participant will proceed to undergo the investigation with the iKOs microcatheter.
The study assessments will be performed through the right radial artery (preference) under local anaesthesia. A sheath will be inserted and a pre-procedure blood sample taken for Troponin T level. A pressure study will then be performed, initially with a pressure wire before using the iKOs™ microcatheter. Both will be performed before and after hyperaemia. Following withdrawal of the iKOs™ microcatheter, a pressure wire assessment is then repeated after the microcatheter is withdrawn. The case will then proceed as clinically indicated. The whole procedure should take about 30-45 minutes. Post-procedure the participant will be managed according to standard clinical practice.
The participant will be discharged home, usually about 4 hours after the end of the procedure. A troponin blood test and ECG will be repeated before they are discharged.
Follow up telephone calls to assess for any complications of the procedure will be made within the first 7 days and again between 6 and 8 weeks after the procedure.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Coronary Stenosis, Coronary Microvascular Disease
Keywords
Heart, Microcatheter, Fibreoptic
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
A single centre, prospective, feasibility study of the iKOs™ coronary pressure and flow rapid-exchange microcatheter and iKOr™ console in patients with coronary heart disease undergoing coronary physiology investigations.
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intra coronary rapid-exchange iKOs microcatheter intervention
Arm Type
Experimental
Arm Description
Patients with coronary heart disease and undergoing coronary physiology investigations (pressure wire measurements) will have additional coronary pressure and flow measurements using the iKOs rapid-exchange microcatheter and iKOr console.
Intervention Type
Device
Intervention Name(s)
Intra coronary rapid-exchange iKOs microcatheter intervention
Other Intervention Name(s)
iKOs Microcatheter
Intervention Description
Patients planned for an invasive coronary physiology (pressure-wire) study and who meet the inclusion criteria and none of the exclusion criteria can be enrolled. Participants will undergo preparation for their clinical procedure (angiogram with pressure wire study) in the normal manner. Arterial cannulation will be performed via the radial or femoral artery) under local anaesthesia. The sheath will be inserted and a pre-procedure blood sample taken for Troponin T level. A coronary angiogram will be performed as per standard clinical practice prior to cannulating the coronary artery to be studied. The pressure studies will be performed sequentially, first with a pressure wire before using the iKOs™ microcatheter. Following withdrawal of the iKOs™ microcatheter. A pressure wire assessment is repeated after the microcatheter is withdrawn. The case will then proceed as clinically indicated. Post-procedure the participant will be managed according to standard clinical practice.
Primary Outcome Measure Information:
Title
To assess the effectiveness of the iKOr system in measuring temperature change (flow) in patients with coronary artery disease undergoing physiology investigations
Description
A change in thermal transit time measured by the iKOr system
Time Frame
Measured immediately prior to adenosine administration (baseline), and during adenosine administration (hyperaemia).
Secondary Outcome Measure Information:
Title
To assess the safety of the iKOs microcatheter in patients undergoing angiography and pressure wire assessment
Description
The number of major adverse cardiac events or patient deaths
Time Frame
Measured at procedure, at 4 hrs post procedure, at 1 week post procedure and 8 weeks post procedure
Title
To assess the safety of the iKOs microcatheter procedure
Description
The number of procedural complications related to the device (operator observed vessel spasm, vascular complications, bleeding)
Time Frame
Measured at procedure, 4 hrs post procedure, at 1 week post procedure and 8 weeks post procedure
Title
To assess the effect of the iKOs microcatheter on cardiac injury
Description
The change in Troponin levels
Time Frame
Troponin T measurement at procedure start and 4 hrs post procedure
Title
To assess the effect of the iKOs microcatheter on TIMI (Thrombolysis In Myocardial Infarction) flow
Description
The change in TIMI (Thrombolysis In Myocardial Infarction) flow
Time Frame
TIMI flow measured immediately prior to insertion of iKOs microcatheter and on removal of the iKOs microcatheter
Other Pre-specified Outcome Measures:
Title
To examine the quality of the temperature recordings
Description
The number of complete temperature measurement recordings and the number of interpretable temperature waveforms
Time Frame
Measured from just prior to adenosine administration (baseline), and during adenosine administration (hyperaemia).
Title
To examine ease of use of the iKOs microcatheter
Description
Time taken for deployment of the microcatheter
Time Frame
Measured at procedure - the time taken from insertion of iKOs microcatheter into guide cath to removal of iKOs microcatheter from guide cath
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Able and willing to give informed consent
>18 years old
Have a clinical diagnosis of coronary artery disease
Undergoing further assessment of a coronary artery with a pressure wire study
Exclusion Criteria:
General
Previous coronary artery bypass grafting.
Non/ST-elevation myocardial infarction as indication for angiography.
Ongoing evidence of ischaemia at rest.
Severe renal impairment (GFR <25).
Severe anaemia (Hb <10).
Heparin allergy.
Atrial fibrillation.
Contraindication to adenosine.
Pregnant or lactating; or female of childbearing potential.
Participation in other interventional studies.
Additional exclusion criteria at Angiogram:
Critical coronary artery stenosis in the vessel which is to be studied (>90%).
Left main stem coronary disease causing a >50% stenosis.
Triple vessel coronary disease.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
R&D Governance Administrator
Phone
+44 (0)20 7882 6826
Email
research.governance@qmul.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anthony Mathur
Organizational Affiliation
Queen Mary University of London
Official's Role
Principal Investigator
Facility Information:
Facility Name
St Bartholomew's Hospital
City
London
State/Province
England
ZIP/Postal Code
EC1A 7BE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
R&D Governance Administrator
Phone
+44 (0)20 7882 6826
Email
research.governance@qmul.ac.uk
First Name & Middle Initial & Last Name & Degree
Ruth Bowles
Phone
+44 (0) 20 3765 8704
Email
R.Bowles@qmul.ac.uk
First Name & Middle Initial & Last Name & Degree
Anthony Mathur
First Name & Middle Initial & Last Name & Degree
Dan Jones
First Name & Middle Initial & Last Name & Degree
Vincent Mccaughan
First Name & Middle Initial & Last Name & Degree
Krishnaraj Rathod
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor
We'll reach out to this number within 24 hrs